Point of Care Diagnostics Market, By Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drugs of Abuse (DoA) Testing, Blood Gluc

Point of Care Diagnostics Market, By Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drugs of Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, Others), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Point of care (POC) diagnostics refers to medical diagnostic testing performed outside a laboratory, near or at the site of patient care. Traditionally, most diagnostic tests were conducted in centralized laboratories. However, POC diagnostics helps deliver faster results, enable quick clinical decisions, and provide treatment immediately without transferring samples to distant labs. Technological advancements have enabled the development of portable and easy-to-use devices suitable for near-patient settings like doctor's offices, emergency rooms, pharmacies, and homes. Rising demand for rapid testing and decentralized healthcare, increasing incidence of infectious diseases and growing elderly population susceptible to chronic conditions can drive the global point of care diagnostics market growth.

Market Dynamics:

Global point of care diagnostics market growth is driven by factors like growing demand for rapid, convenient and real-time test results, increasing prevalence of chronic and infectious diseases, rising geriatric population worldwide, technological advancements leading to development of user-friendly and portable POC devices. However, lack of infrastructure and skilled professionals in developing nations, high cost of advanced POC devices, and unreliable test results associated with some devices can hamper the market growth. Moreover, untapped opportunities in emerging markets, integration of advanced technologies like AI and IoT with POC devices, and growing applications of POC testing in home healthcare can offer significant opportunities for the market players.

Key features of the study:

This report provides in-depth analysis of the global point of care diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global point of care diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global point of care diagnostics market

Detailed Segmentation-

By Technology Insights (Revenue, USD Bn, 2019 - 2031)

Lateral Flow

Agglutination Assays

Flow-Through

Solid Phase

Biosensors

By Application Insights (Revenue, USD Bn, 2019 - 2031)

Cardio Metabolic Testing

Infectious Disease Testing

Nephrology Testing

Drugs of Abuse (DoA) Testing

Blood Glucose Testing

Pregnancy Testing

Cancer Biomarker Testing

Others

By End User Insights (Revenue, USD Bn, 2019 - 2031)

Hospitals

Diagnostic Laboratories

Home-Care Settings

Others

By Regional Insights (Revenue, USD Bn, 2019 - 2031)

North America

U.S.

Canada

Latin America

Brazil

Argentina

Mexico

Rest of Latin America

Europe

Germany

U.K.

Spain

France

Italy

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

GCC Countries

Israel

Rest of Middle East

Africa

South Africa

North Africa

Central Africa

Key Players Insights

Hoffmann-La Roche Ltd

Abbott Laboratories

Siemens Healthineers AG

Becton, Dickinson and Company

Qiagen Inc.

Johnson & Johnson Services, Inc.

Danaher Corporation (Beckman Coulter Inc.)

Instrumentation Laboratory

Nova Biomedical Corporation

Biomeriux SA

GE Healthcare

Philips Healthcare

Quest Diagnostics

Fujifilm Medical

Thermo Fisher Scientific

Hologic

Canon

IDEXX Laboratories

Sysmex

QuidelOrtho